Long Position on RMD @ $36.40 on 8/14/2012 (Momentum)

ResMed (RMD) engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

It offers various products for the treatment of obstructive sleep apnea and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear, ventilation devices, and other accessories, such as cold passover humidifiers, carry bags, and breathing circuits.

The company also offers data communications and data control products, such as ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators.

ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third party payers. The company sells its products through a network of distributors, independent manufacturers, representatives, and direct sales force in approximately 70 countries primarily in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Norway, and Sweden.

Shares have formed a bullish "flag" following the realease of its quarterly results and guidance going forward. Stockwinners.com believes shares will break out of this formation to the upside.

52-Week Trading Range: $23.37 - $36.34

Earnings Per Share:    $1.71

Dividend & Yield:   0.68 (1.90%)

Last Trade:    $36.40

Stop Loss:  $34.58

Target Price:  $40.05

Updates

9/14/2012 2:08:18 PM

We reached our 30-days time limit.

Position closed on 9/14/2012 at price of $39.50 with a 8.52% gain in 31 days.

Back to Portfolio